Logo image of QTRX

QUANTERIX CORP (QTRX) Stock Overview

USA - NASDAQ:QTRX - US74766Q1013 - Common Stock

5.505 USD
-0.08 (-1.34%)
Last: 9/19/2025, 3:34:01 PM

QTRX Key Statistics, Chart & Performance

Key Statistics
52 Week High15.67
52 Week Low4.05
Market Cap255.82M
Shares46.47M
Float43.46M
Yearly DividendN/A
Dividend YieldN/A
EPS(TTM)-1.51
PEN/A
Fwd PEN/A
Earnings (Next)11-10 2025-11-10/amc
IPO12-07 2017-12-07
Sector
GICS SectorHealth Care
GICS IndustryLife Sciences Tools & Services
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences


QTRX short term performance overview.The bars show the price performance of QTRX in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 10 -10 20 -20

QTRX long term performance overview.The bars show the price performance of QTRX in the last 1, 2 and 3 years. 1 year 2 years 3 years -20 -40 -60

The current stock price of QTRX is 5.505 USD. In the past month the price increased by 13.65%. In the past year, price decreased by -61.62%.

QUANTERIX CORP / QTRX Daily stock chart

QTRX Competitors/Peers

The largest stocks on the US markets in the "Life Sciences Tools & Services" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
TMO THERMO FISHER SCIENTIFIC INC 22.05 182.23B
DHR DANAHER CORP 25.72 138.68B
A AGILENT TECHNOLOGIES INC 23.31 36.01B
IQV IQVIA HOLDINGS INC 16.43 32.03B
MTD METTLER-TOLEDO INTERNATIONAL 30.93 26.06B
WST WEST PHARMACEUTICAL SERVICES 36.65 18.34B
WAT WATERS CORP 24.82 18.07B
ILMN ILLUMINA INC 24.93 15.94B
TEM TEMPUS AI INC N/A 15.29B
MEDP MEDPACE HOLDINGS INC 36.93 13.95B
ICLR ICON PLC 13.33 13.71B
RVTY REVVITY INC 17.8 10.10B

About QTRX

Company Profile

QTRX logo image Quanterix Corp. engages in the development of ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics. The company is headquartered in Billerica, Massachusetts and currently employs 471 full-time employees. The company went IPO on 2017-12-07. The Company’s Simoa technology delivers earlier biomarker detection in blood, serum or plasma, with the ability to quantify proteins that are far lower than the level of quantification (LoQ). Its precision instruments, digital immunoassay technology and CLIA-certified Accelerator laboratory have supported research that advances disease understanding and management in neurology, oncology, immunology, cardiology and infectious disease. Its products and services include Simoa Assay Kits, Simoa Dry Blood Extraction Kit, LDTs & Assay Services, Instruments, Simoa Accelerator Laboratory, Homebrew-Custom Assay Development, and Nova Beads. LDTs & Assay Services include Simoa p-Tau 217, Simoa NfL LDT, and LucentAD pTau 217. Its instruments include Simoa HD-X Analyzer-Automated Immunoassays, Quanterix SR-X Biomarker Detection System, and SP-X Imaging and Analysis System.

Company Info

QUANTERIX CORP

900 Middlesex Turnpike

Billerica MASSACHUSETTS 01821 US

CEO: E. Kevin Hrusovsky

Employees: 471

QTRX Company Website

QTRX Investor Relations

Phone: 16173019400

QUANTERIX CORP / QTRX FAQ

What is the stock price of QUANTERIX CORP today?

The current stock price of QTRX is 5.505 USD. The price decreased by -1.34% in the last trading session.


What is the ticker symbol for QUANTERIX CORP stock?

The exchange symbol of QUANTERIX CORP is QTRX and it is listed on the Nasdaq exchange.


On which exchange is QTRX stock listed?

QTRX stock is listed on the Nasdaq exchange.


What is the price forecast or stock price prediction for QUANTERIX CORP stock?

9 analysts have analysed QTRX and the average price target is 6.38 USD. This implies a price increase of 15.8% is expected in the next year compared to the current price of 5.505. Check the QUANTERIX CORP stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is QUANTERIX CORP worth?

QUANTERIX CORP (QTRX) has a market capitalization of 255.82M USD. This makes QTRX a Micro Cap stock.


How many employees does QUANTERIX CORP have?

QUANTERIX CORP (QTRX) currently has 471 employees.


What are the support and resistance levels for QUANTERIX CORP (QTRX) stock?

QUANTERIX CORP (QTRX) has a support level at 5.25 and a resistance level at 6.34. Check the full technical report for a detailed analysis of QTRX support and resistance levels.


Is QUANTERIX CORP (QTRX) expected to grow?

The Revenue of QUANTERIX CORP (QTRX) is expected to decline by -2.27% in the next year. Check the estimates tab for more information on the QTRX EPS, Sales, EBIT and EBITDA future analyst estimates.


Should I buy QUANTERIX CORP (QTRX) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does QUANTERIX CORP (QTRX) stock pay dividends?

QTRX does not pay a dividend.


When does QUANTERIX CORP (QTRX) report earnings?

QUANTERIX CORP (QTRX) will report earnings on 2025-11-10, after the market close.


What is the Price/Earnings (PE) ratio of QUANTERIX CORP (QTRX)?

QUANTERIX CORP (QTRX) does not have a PE ratio as the earnings reported over the last twelve months were negative (-1.51).


What is the Short Interest ratio of QUANTERIX CORP (QTRX) stock?

The outstanding short interest for QUANTERIX CORP (QTRX) is 9.68% of its float. Check the ownership tab for more information on the QTRX short interest.


QTRX Technical Analysis

ChartMill assigns a technical rating of 2 / 10 to QTRX. When comparing the yearly performance of all stocks, QTRX is a bad performer in the overall market: 94.94% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating

QTRX Fundamental Analysis

ChartMill assigns a fundamental rating of 3 / 10 to QTRX. While QTRX has a great health rating, there are worries on its profitability.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

QTRX Financial Highlights

Over the last trailing twelve months QTRX reported a non-GAAP Earnings per Share(EPS) of -1.51. The EPS decreased by -43.81% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -18.77%
ROE -24.11%
Debt/Equity 0
Chartmill High Growth Momentum
EPS Q2Q%-128%
Sales Q2Q%-28.81%
EPS 1Y (TTM)-43.81%
Revenue 1Y (TTM)-22.06%

QTRX Forecast & Estimates

9 analysts have analysed QTRX and the average price target is 6.38 USD. This implies a price increase of 15.8% is expected in the next year compared to the current price of 5.505.

For the next year, analysts expect an EPS growth of -121.83% and a revenue growth -2.27% for QTRX


Analysts
Analysts48.89
Price Target6.38 (15.89%)
EPS Next Y-121.83%
Revenue Next Year-2.27%

QTRX Ownership

Ownership
Inst Owners73.15%
Ins Owners5.85%
Short Float %9.68%
Short Ratio5.91